الابحاث

South Egypt Cancer Institute

Assiut University

Department of Clinical Pathology
# Title Research Member Research Year
41 Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer Dr. Asmaa Mohamed Zahran Omar 2022
42 Sinopharm’s BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2 Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2022
43 Prognostic outcome of mesenchymal transition biomarkers in correlation with EGFR expression in epithelial ovarian carcinoma patients Israa Mostafa Kamal Mohammed 2022
44 Overexpression of PD-1 and CD39 in tumor-infiltrating lymphocytes compared with peripheral blood lymphocytes in triple-negative breast cancer Dr. Dalia Osama Mohamed Ahmed 2022
45 Sinopharm’s BBIBP-CorV Vaccine and ChAdOx1 nCoV-19 Vaccine Are Associated with a Comparable Immune Response against SARS-CoV-2 Dr. Iman Hassan Ahmed Hamada 2022
46 Prognostic outcome of mesenchymal transition biomarkers in correlation with EGFR expression in epithelial ovarian carcinoma patients Prof. Eman Massad Zaki El-Hefny 2022
47 Evaluation of new markers of minimal residual disease in B acute lymphoblastic leukemia Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2022
48 Association of follicular helper T and follicular regulatory T cells with severity and hyperglycemia in hospitalized COVID-19 patients Dr. Asmaa Mohamed Zahran Omar 2022
49 Genetic variation in FOXP3 and ROR‑γ genes in pediatric acute lymphocytic leukemia (ALL) patients: correlation with associated cytokines Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2022
50 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Dr. Mohamed Galal Mostafa ELnaggar 2021